Importantly, the nuance in offering GLP-1s is that employers want to ensure they get into the hands of the employees that stand to benefit most and thus get the most value out of the medicines, so I expect we will see additional restrictions put in place to control coverage of these medicines, in the form of prior authorizations and other controlled access
In the dark nights of my soul, I fret about how inconsistently engineered my life is
Week 8 to 12: the adaptation window Clinical trials consistently show that most GI symptoms, including diarrhea, diminish significantly after 8 to 12 weeks, particularly in participants who followed gradual dose-escalation schedules
This work was supported by the Lundbeck Foundation (fellowship R238-2016-2859), the BioInnovation Institute (grant number NNF20OC0063538) and the Novo Nordisk Foundation (grant numbers NNF17OC0026114 and NNF22OC0073778)
What causes GLP-1 skin itch